Lawrence N J, Rennison D, Woo M, McGown A T, Hadfield J A
Department of Chemistry, UMIST, Manchester, UK.
Bioorg Med Chem Lett. 2001 Jan 8;11(1):51-4. doi: 10.1016/s0960-894x(00)00596-5.
A series of diarylamines, diaryl and arylbenzyl ethers based on combretastatin A-4 was prepared and evaluated for anticancer activity. 2-Methoxy-5-(3',4',5'-trimethoxyphenoxymethyl)phenol was the most active (IC50, K562 20 nM) and caused significant G2/M cell cycle arrest.
制备了一系列基于康普他汀A-4的二芳基胺、二芳基醚和芳基苄基醚,并对其抗癌活性进行了评估。2-甲氧基-5-(3',4',5'-三甲氧基苯氧基甲基)苯酚活性最高(IC50,K562 20 nM),并引起显著的G2/M期细胞周期阻滞。